ADRIAMYCIN AND MITOMYCIN-C - POSSIBLE SYNERGISTIC CARDIOTOXICITY

被引：0
|
作者：
BUZDAR, AU
LEGHA, SS
TASHIMA, CK
HORTOBAGYI, GN
YAP, HY
KRUTCHIK, AN
LUNA, MA
BLUMENSCHEIN, GR
机构：
[1] UNIV TEXAS SYST,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT DEV THERAPEUT,HOUSTON,TX 77030
[2] UNIV TEXAS SYST,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT PATHOL,HOUSTON,TX 77030
来源：
CANCER TREATMENT REPORTS | 1978年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1008
页数：4
相关论文
共 50 条
  • [31] 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C IN ADENOCARCINOMA OF THE ESOPHAGUS OR GASTROESOPHAGEAL JUNCTION TUMORS
    KHANSUR, T
    ALLRED, C
    TAVASSOLI, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (06): : 506 - 508
  • [32] 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C (FAM) CHEMOTHERAPY FOR ADVANCED ADENOCARCINOMA OF THE PANCREAS
    SMITH, FP
    HOTH, DF
    LEVIN, B
    KARLIN, DA
    MACDONALD, JS
    WOOLLEY, PV
    SCHEIN, PS
    CANCER, 1980, 46 (09) : 2014 - 2018
  • [33] FLUOROURACIL(F), ADRIAMYCIN(A) AND MITOMYCIN-C(M), FAM, FOR ADVANCED COLORECTAL AND PANCREATIC CANCER
    HALLER, D
    WOOLLEY, P
    LEVIN, B
    UENO, W
    MACDONALD, J
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 342 - 342
  • [34] COMBINATION CHEMOTHERAPY OF GASTRIC CANCER WITH FLUORO-URACIL, ADRIAMYCIN AND MITOMYCIN-C (FAM)
    SCHEIN, PS
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1977, 3 : S29 - S29
  • [35] ADRIAMYCIN (DOXORUBICIN), VINBLASTINE, AND MITOMYCIN-C COMBINATION CHEMOTHERAPY IN REFRACTORY BREAST-CARCINOMA
    LUIKART, SD
    WITMAN, GB
    PORTLOCK, CS
    CANCER, 1984, 54 (07) : 1252 - 1255
  • [36] FLUOROURACIL (F), ADRIAMYCIN (A) AND MITOMYCIN-C (M), FAM, FOR ADENOCARCINOMA OF UNKNOWN ORIGIN (AUO)
    MCKEEN, E
    SMITH, F
    HAIDAK, D
    BUTLER, T
    HOTH, D
    WOOLLEY, P
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 358 - 358
  • [37] PERMEABILITY OF THE RAT BLADDER TO CISPLATINUM UNDER DIFFERENT CONDITIONS - COMPARISON WITH MITOMYCIN-C AND ADRIAMYCIN
    ENGELMANN, U
    OELSNER, G
    BURGER, RA
    WAGNER, H
    UROLOGICAL RESEARCH, 1983, 11 (01): : 39 - 42
  • [38] 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C (FAM) IN THE TREATMENT OF INOPERABLE ADENOCARCINOMA OF THE LUNG
    SHEPHERD, FA
    EVANS, WK
    BURKES, R
    PAUL, K
    DEBOER, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (05): : 392 - 396
  • [39] CHARACTERIZATION OF LIPOSOMES AND AN EMULSION CONTAINING MITOMYCIN-C OR LIPOPHILIC MITOMYCIN-C PRODRUGS
    SASAKI, H
    KAKUTANI, T
    HASHIDA, M
    SEZAKI, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (12) : 1166 - 1170
  • [40] ADRIAMYCIN CARDIOTOXICITY - POSSIBLE PATHOGENIC MECHANISMS
    AZUMA, J
    SPERELAKIS, N
    HASEGAWA, H
    TANIMOTO, T
    VOGEL, S
    OGURA, K
    AWATA, N
    SAWAMURA, A
    HARADA, H
    ISHIYAMA, T
    MORITA, Y
    YAMAMURA, Y
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1981, 13 (04) : 381 - 397
12345